Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements Regarding its Mercury UV Device and Xenex Germ-Zapping Robots

SAN ANTONIO--(BUSINESS WIRE)--A Bexar County District Court issued a Temporary Restraining Order today against Tru Defense Inc. (Tru-D), which forces Tru-D to end its practice of making false and misleading statements regarding the efficacy of its mercury bulb product, said Xenex Disinfection Services.

The Court found that the Order was necessary because Tru-D has “already made and is continuing to publish false and misleading statements about [Xenex’s] product.” The Court ordered Tru-D to immediately cease publishing false and misleading statements about [Xenex] and its product.

Tru-D is the manufacturer of the Tru-D Smart UV device, a mercury bulb ultraviolet (UV) light system marketed to hospitals to disinfect surfaces and remove the pathogens that can cause hospital acquired infections (HAIs). Independent peer-reviewed studies of the Tru-D device consistently show that Tru-D’s efficacy claims are false and/or misleading, as they materially misstate the effectiveness of the Tru-D product. For example, Tru-D falsely claims its device is capable of disinfecting an entire room from a single position, specifically including shadowed areas, ignoring peer-reviewed studies that show that its device does not remove all pathogens from these areas as claimed.

The Court also forced Tru-D to stop making false statements regarding the Germ-Zapping Robot™ manufactured and sold by Xenex Disinfection Services, which uses Pulsed Xenon Full Spectrum™ UV to create germicidal light. In its marketing literature, Tru-D materially overstates the effectiveness of its mercury device, while grossly understating the effectiveness of Xenex’s Pulsed Xenon Full Spectrum™ UV device.

There are material technological differences between the mercury bulb UV technology used by Tru-D and the Pulsed Xenon Full Spectrum™ UV room disinfection technology used by Xenex. Tru-D’s product uses bulbs that contain toxic mercury to produce low intensity, narrow spectrum UV light. The Xenex Germ-Zapping Robot™ uses a patented pulsed xenon technology to produce intense UV light that covers the entire UV light spectrum.

The Xenex pulsed xenon UV technology is significantly faster than the Tru-D product, which allows hospitals to disinfect more rooms per day/per device to reduce the facility’s bioburden. Most importantly, hospitals using Xenex robots have shown, in multiple peer-reviewed published studies, reductions in HAI rates greater than 50 percent. There are no peer-reviewed published studies that show that any hospital has successfully reduced its HAI rates using the Tru-D device. The Xenex Germ-Zapping Robot is the only UV disinfection technology that has been shown, in multiple peer-reviewed published outcome studies, to help hospitals reduce HAI rates.

“There are more than 50 companies that sell UV systems that rely on mercury bulbs similar to Tru-D. Tru-D uses false marketing claims in an attempt to convince hospitals that their products have capabilities that do not exist. Xenex has shown, in multiple peer-reviewed studies, that we can help hospitals reduce their infection rates by destroying the deadly pathogens that cause them. Tru-D’s technology was on the market for several years before ours, and to date there are no peer-reviewed published studies that demonstrate that Tru-D’s device has any impact on infection rates. We intend to monitor and react to any false statements made by any mercury company about Xenex and our unique pulsed Xenon technology and this TRO will force them to be truthful moving forward,” said Morris Miller, CEO of Xenex.

MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson Health Care (an affiliate of Massachusetts General Hospital and Partners HealthCare System) and other hospitals have published 14 studies providing evidence of the Xenex robot’s efficacy in highly regarded scientific journals that include AJIC, the Journal of Infection Prevention, ICHE and BMC Infectious Diseases. Xenex robots are in more than 300 hospitals, Veterans Affairs (VA), Department of Defense (DoD), long-term acute care and skilled nursing facilities, and outpatient surgery centers in the U.S., Europe, Canada and Africa.

About Xenex Disinfection Services
Xenex's patented Full Spectrum™ pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to save lives and reduce suffering by eliminating the deadly microorganisms that cause HAIs. The company is backed by well-known investors that include Malin Corporation, Battery Ventures, Targeted Technology Fund II and RK Ventures. For more information, visit www.xenex.com.

Source: http://www.businesswire.com/news/ back

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more